3rd Quarter - Report

THORN RUN PARTNERS for NOVARTIS CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 19, 2018 $60,000 Replaced
3rd Quarter - Amendment Jan 18, 2019 $50,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to the Orphan Drug Tax.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —
CHARLES B. THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Neonatal drug issues.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —
CHARLES B. THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Issues related to the Part D coverage gap and the Medicare reimbursement of biosimilars.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —
CHARLES B. THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Issues related to biologics.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —
CHARLES B. THOMAS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.